These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 6307103

  • 21. Activity of beta-lactamase inhibitors in combination with new beta-lactam antibiotics against resistant gram-negative organisms.
    Bolivar R, Weaver SS, Bodey GP.
    Diagn Microbiol Infect Dis; 1984 Jun; 2(3):255-60. PubMed ID: 6086213
    [Abstract] [Full Text] [Related]

  • 22. Comparative activity in vitro of ticarcillin and ticarcillin plus clavulanic acid against Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter calcoaceticus.
    Campos P, Vera A, Martin-Luengo F.
    Chemioterapia; 1987 Jun; 6(2 Suppl):77-8. PubMed ID: 3151358
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin.
    Aronoff SC, Jacobs MR, Johenning S, Yamabe S.
    Antimicrob Agents Chemother; 1984 Oct; 26(4):580-2. PubMed ID: 6097169
    [Abstract] [Full Text] [Related]

  • 26. Influence of beta-lactamase inhibitors on the activity of oxacillin against methicillin-resistant Staphylococcus aureus.
    Chang SC, Hsieh WC, Luh KT.
    Diagn Microbiol Infect Dis; 1995 Feb; 21(2):81-4. PubMed ID: 7628197
    [Abstract] [Full Text] [Related]

  • 27. False extended-spectrum beta-lactamase detection in Acinetobacter spp. due to intrinsic susceptibility to clavulanic acid.
    Beceiro A, Fernández-Cuenca F, Ribera A, Martínez-Martínez L, Pascual A, Vila J, Rodríguez-Baño J, Cisneros JM, Pachón J, Bou G, Spanish Group for Nosocomial Infection (GEIH).
    J Antimicrob Chemother; 2008 Feb; 61(2):301-8. PubMed ID: 18065824
    [Abstract] [Full Text] [Related]

  • 28. Activities of various beta-lactams and beta-lactam/beta-lactamase inhibitor combinations against Acinetobacter baumannii and Acinetobacter DNA group 3 strains.
    Brauers J, Frank U, Kresken M, Rodloff AC, Seifert H.
    Clin Microbiol Infect; 2005 Jan; 11(1):24-30. PubMed ID: 15649300
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Differences between clavulanic acid and sulbactam in induction and inhibition of cephalosporinases in enterobacteria.
    Kazmierczak A, Cordin X, Duez JM, Siebor E, Pechinot A, Sirot J.
    J Int Med Res; 1990 Jan; 18 Suppl 4():67D-77D. PubMed ID: 2282971
    [Abstract] [Full Text] [Related]

  • 31. The effects of three beta-lactamase inhibitors: YTR830H, sulbactam and clavulanic acid on the growth of human cells in culture.
    Yamabe S, Adachi K, Watanabe M, Ueda S.
    Chemioterapia; 1987 Oct; 6(5):337-40. PubMed ID: 2827899
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. In vitro susceptibility of Campylobacter jejuni to 27 antimicrobial agents and various combinations of beta-lactams with clavulanic acid or sulbactam.
    Van der Auwera P, Scorneaux B.
    Antimicrob Agents Chemother; 1985 Jul; 28(1):37-40. PubMed ID: 2994557
    [Abstract] [Full Text] [Related]

  • 36. [Bactericide activity of sulbactam before bacteria belonging to the Acinetobacter calcoaceticus-Acinetobacter baumannii complex].
    Villar HE, Laurino G, Hoffman M.
    Enferm Infecc Microbiol Clin; 1996 Nov; 14(9):524-7. PubMed ID: 9035707
    [Abstract] [Full Text] [Related]

  • 37. Beta-lactamase inhibition by acetylmethylene penicillanic acid compared to that of clavulanate and sulbactam.
    Chin NX, McElrath MJ, Neu HC.
    Chemotherapy; 1988 Nov; 34(4):318-25. PubMed ID: 2850139
    [Abstract] [Full Text] [Related]

  • 38. Increase in the activity of third-generation cephalosporins in combination with clavulanic acid and Sulbactam against Bacteroides fragilis.
    Martín MA, Castillo AM, Liebana J, Mesa P, Piedrola G, Gutierrez J.
    Med Lab Sci; 1990 Jul; 47(3):163-7. PubMed ID: 2402195
    [Abstract] [Full Text] [Related]

  • 39. Effect of beta-lactamase inhibitors on minimum inhibitory concentration of ampicillin and amoxicillin for Staphylococcus aureus strains.
    Paniagua GL, Monroy E, García O, Vaca S.
    Rev Latinoam Microbiol; 1998 Jul; 40(3-4):128-34. PubMed ID: 10932741
    [Abstract] [Full Text] [Related]

  • 40. Susceptibility of the Acinetobacter calcoaceticus-A. baumannii complex to imipenem, meropenem, sulbactam and colistin.
    Dueñas Díez AI, Bratos Pérez MA, Eiros Bouza JM, Almaraz Gómez A, Gutiérrez Rodríguez P, Miguel Gómez MA, Orduña Domingo A, Rodríguez-Torres A.
    Int J Antimicrob Agents; 2004 May; 23(5):487-93. PubMed ID: 15120728
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.